Literature DB >> 1383872

Amyloidoma of the CNS. II. Immunohistochemical and biochemical study.

R G Vidal1, J Ghiso, G Gallo, M Cohen, P L Gambetti, B Frangione.   

Abstract

We present the immunohistochemical and biochemical identification of an amyloidoma localized to the cerebral white matter in a patient who shows no evidence of systemic or extracranial localized amyloid deposits. Immunohistologic and immunochemical studies, using antibodies against biochemically different amyloid fibrils and amyloid-associated proteins, showed reactivity with antibodies only to lambda light chain and serum amyloid P-component. Amino acid sequence analysis of the purified amyloid fibrils extracted from the brain tumor indicates that the amyloid protein is an unusual immunoglobulin lambda light chain, starting at residue five of the variable domain. These fibrils consist of lambda chain fragments of different lengths (10 to 30 kd) very likely arising by polymerization of the amyloid subunit or sequential proteolytic cleavage of the light chain, or both. After exposure to denaturing agents, the 10-kd subunit retains the characteristics of native amyloid fibrils by electron microscopy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1383872     DOI: 10.1212/wnl.42.10.2024

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

Review 1.  Imaging of focal amyloid depositions in the head, neck, and spine: amyloidoma.

Authors:  Hemant Parmar; T Rath; M Castillo; D Gandhi
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-14       Impact factor: 3.825

2.  Cerebral amyloid angiopathy presenting as nonhemorrhagic diffuse encephalopathy: neuropathologic and neuroradiologic manifestations in one case.

Authors:  M Caulo; D Tampieri; R Brassard; M Christine Guiot; D Melanson
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

3.  Imaging of cerebral and brain stem amyloidomas.

Authors:  S C Symko; E M Hattab; G K Steinberg; B Lane
Journal:  AJNR Am J Neuroradiol       Date:  2001-08       Impact factor: 3.825

Review 4.  Monoclonal origin of localised orbital amyloidosis detected by molecular analysis.

Authors:  S Pasternak; V A White; R D Gascoyne; S R Perry; R L Johnson; J Rootman
Journal:  Br J Ophthalmol       Date:  1996-11       Impact factor: 4.638

Review 5.  Cerebral amyloidosis: amyloid subunits, mutants and phenotypes.

Authors:  A Rostagno; J L Holton; T Lashley; T Revesz; Jorge Ghiso
Journal:  Cell Mol Life Sci       Date:  2009-11-07       Impact factor: 9.261

Review 6.  CT and MR imaging of intracerebral amyloidoma: case report and review of the literature.

Authors:  Dheeraj Gandhi; Roberto Wee; Mayank Goyal
Journal:  AJNR Am J Neuroradiol       Date:  2003-03       Impact factor: 3.825

7.  AL kappa amyloid in a solitary extradural lymphoma.

Authors:  D M Vigushin; P N Hawkins; J J Hsuan; N F Totty; M B Pepys
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-06       Impact factor: 10.154

8.  Multiple intracranial cavernomas with focal amyloid deposition - diagnostic pitfalls.

Authors:  T Velnar; G Bunc; D Flisar; D Kulaš; A Woehrer; H Budka; M Popoviä
Journal:  Clin Neuropathol       Date:  2011 Nov-Dec       Impact factor: 1.368

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.